NRP Stock Recent News
NRP LATEST HEADLINES
NRP Q2 earnings drop on lower coal and soda ash prices, but strong cash flow keeps debt paydown and higher 2026 payouts on track.
Natural Resource Partners L.P. Common Units (NYSE:NRP ) Q2 2025 Earnings Conference Call August 6, 2025 9:00 AM ET Company Participants Christopher J.
HOUSTON--(BUSINESS WIRE)--Natural Resource Partners L.P. (NYSE:NRP) today reported second quarter 2025 results as follows: For the Three Months Ended Last Twelve Months Ended (In thousands) (Unaudited) June 30, 2025 Net income $ 34,211 $ 155,831 Operating cash flow 45,579 200,368 Free cash flow (1) 46,293 203,141 __________________________ (1) See "Non-GAAP Financial Measures" and reconciliation tables at the end of this release. Highlights: Generat.
HOUSTON--(BUSINESS WIRE)--Natural Resource Partners L.P. (NYSE: NRP) plans to report its second quarter 2025 financial results before the market opens on Wednesday, August 6, 2025. Management will host a conference call beginning at 9:00 a.m. ET to discuss the results. To register for the conference call please use this link: https://registrations.events/direct/Q4I1544858. After registering, a confirmation will be sent via email and include dial-in details and unique conference call codes for e.
HOUSTON--(BUSINESS WIRE)--Natural Resource Partners L.P. (NYSE: NRP) announced today that its 2024 Schedule K-3 reflecting items of international tax relevance is available online. Unitholders may access the information at www.taxpackagesupport.com/naturalresource. A limited number of unitholders (primarily foreign unitholders, unitholders computing a foreign tax credit on their tax return and certain corporate and/or partnership unitholders) may need the detailed information disclosed on Sched.
NRP's Q1 earnings drop amid falling coal and soda ash prices despite a strong free cash flow and ongoing debt reduction efforts.
Natural Resource Partners L.P. Common Units (NYSE:NRP ) Q1 2025 Results Conference Call May 6, 2025 9:00 AM ET Company Participants Tiffany Sammis - Investor Relations Craig Nunez - President & Chief Operating Officer Chris Zolas - Chief Financial Officer Conference Call Participants John Mason - Aegis Company Operator Hello, and welcome to the Natural Resource Partners L.P.
In addition to securing new contracts from the Ohio Department of Natural Resources covering 10 well sites to be remediated, Zefiro subsidiary Plants & Goodwin, Inc. also earned a collection of projects from two private-sector customers covering an additional 15 well sites, solidifying the Company's increasing commercial footprint in Ohio and Pennsylvania. In addition to securing new contracts from the Ohio Department of Natural Resources covering 10 well sites to be remediated, Zefiro subsidiary Plants & Goodwin, Inc. also earned a collection of projects from two private-sector customers covering an additional 15 well sites, solidifying the Company's increasing commercial footprint in Ohio and Pennsylvania.
SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced that the Company will present a poster featuring preclinical data for ATYR2810, a monoclonal antibody targeting neuropilin-2 (NRP2), at the American Association for Cancer Research (AACR) Annual Meeting 2025, which is being held April 25 – 30, 2025, in Chicago, IL. “Aggressive cancers like glioblastoma multiforme (GBM) continue to show drug resistance, and the efficacy of current immunotherapies may be limited due to immunosuppressive myeloid cells in the tumor microenvironment that contribute to drug resistance.